Literature DB >> 31850455

BODIPYs revealing lipid droplets as valuable targets for photodynamic theragnosis.

Andrea Tabero1, Fernando García-Garrido2, Alejandro Prieto-Castañeda2, Eduardo Palao2, Antonia R Agarrabeitia2, Inmaculada García-Moreno3, Angeles Villanueva4, Santiago de la Moya2, María J Ortiz2.   

Abstract

Endowing BODIPY PDT agents with the ability to probe lipid droplets is demonstrated to boost their phototoxicity, allowing the efficient use of highly fluorescent dyes (poor ROS sensitizers) as phototoxic agents. Conversely, this fact opens the way to the development of highly bright ROS photosensitizers for performing photodynamic theragnosis (fluorescence bioimaging and photodynamic therapy) from a single simple agent. On the other hand, the noticeable capability of some of the reported dyes to probe lipid droplets in different cell lines under different conditions reveals their use as privileged probes for advancing the study of interesting lipid droplets by fluorescence microscopy.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31850455     DOI: 10.1039/c9cc09397d

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  3 in total

1.  Organolithium-Mediated Postfunctionalization of Thiazolo[3,2-c][1,3,5,2]oxadiazaborinine Fluorescent Dyes.

Authors:  Mykhaylo A Potopnyk; Dmytro Volyniuk; Roman Luboradzki; Magdalena Ceborska; Iryna Hladka; Yan Danyliv; Juozas V Grazulevicius
Journal:  J Org Chem       Date:  2020-04-21       Impact factor: 4.354

Review 2.  Lipid Droplets in Cancer: From Composition and Role to Imaging and Therapeutics.

Authors:  Patrícia Antunes; Adriana Cruz; José Barbosa; Vasco D B Bonifácio; Sandra N Pinto
Journal:  Molecules       Date:  2022-02-01       Impact factor: 4.411

3.  Multiple Light-Activated Photodynamic Therapy of Tetraphenylethylene Derivative with AIE Characteristics for Hepatocellular Carcinoma via Dual-Organelles Targeting.

Authors:  Chuxing Chai; Tao Zhou; Jianfang Zhu; Yong Tang; Jun Xiong; Xiaobo Min; Qi Qin; Min Li; Na Zhao; Chidan Wan
Journal:  Pharmaceutics       Date:  2022-02-21       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.